Advertisements


Biotech Stock On The Radar: Is Vanda A Buy Ahead Of Its PDUFA Date?

Small-cap biopharma Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) has withstood the market-wide sell-off witnessed in early August, thanks to the second-quarter report the company issued July 31. read more.....»»

Category: blogSource: benzingaAug 13th, 2019

Biotech Stock On The Radar: Assessing Mirati"s Oncology Franchise With An Eye On Multiple Readouts

Mirati Therapeutics Inc (NASDAQ: MRTX), a thinly traded, smid-cap oncology biotech, is on investors' radars ahead of upcoming conference presentations and data readouts. read more.....»»

Category: blogSource: benzingaOct 16th, 2019

Pfenex Gets FDA Seal of Approval For Amgen"s Forteo Biosimilar

Shares of the micro-cap biotech Pfenex Inc (NYSE: PFNX), which pulled back ahead of the PDUFA date for its Forteo biosimilar PF708, were advancing Monday amid a positive outcome for the read more.....»»

Category: blogSource: benzingaOct 7th, 2019

Biotech Stock On The Radar: FDA Verdict Ahead For Pfenex"s Osteoporosis Biosimilar

Pfenex Inc (NYSE: PFNX) has a key binary event coming up: mark your calendar for Oct. 7, when the FDA is scheduled to issue its verdict on the company's lead drug candidate. read more.....»»

Category: blogSource: benzingaOct 3rd, 2019

Biotech Stock On The Radar: vTv Therapeutics" Diabetes Pipeline

The thinly traded micro-cap biotech vTv Therapeutics Inc (NASDAQ: VTVT) is on investors' radars ahead of a Sept. 18 poster presentation of clinical data. read more.....»»

Category: blogSource: benzingaSep 17th, 2019

Biotech Stock On The Radar: Aimmune Awaits Adcom Test

Aimmune Therapeutics Inc (NASDAQ: AIMT) shares have been on an extended downtrend since the start of 2018. This thinly traded, small-cap biotech is on the radar ahead of a key FDA panel meeting scheduled for Friday, Sept. 13. read more.....»»

Category: blogSource: benzingaSep 10th, 2019

Biotech Stock On The Radar: Ardelyx Gears Up For FDA Decision Day

Shares of the thinly traded, micro-cap biotech Ardelyx Inc (NASDAQ: ARDX) have risen over 200% year-to-date. With a key binary event coming up, it's time for a look at what the future holds for the equity.  read more.....»»

Category: blogSource: benzingaSep 4th, 2019

Biotech Stock On The Radar: Veru, A Catalyst-Rich Biopharma

Thinly traded micro-cap Veru Inc (NASDAQ: VERU) has added about 62% year to date — a commendable performance compared to the broader biotech sector. read more.....»»

Category: blogSource: benzingaJul 31st, 2019

Biotech Stock On The Radar: Nabriva And Its Novel Antibiotic Portfolio

Nabriva Therapeutics PLC – ADR (NASDAQ: NBRV) share.....»»

Category: blogSource: benzingaNov 20th, 2019

Piper says Alnylam granted Givlaari approval three months ahead of PDUFA date

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 20th, 2019

Biotech Stock On The Radar: Alkermes At A Crossroads

Alkermes Plc (NASDAQ: ALKS), an actively t.....»»

Category: blogSource: benzingaNov 7th, 2019

Citi Steps To Sidelines On Adobe

As of Tuesday, Adobe Inc (NASDAQ: ADBE) stock is up 24.4% year-to-date — five points ahead of market indices. But its run isn’t enoug.....»»

Category: blogSource: benzingaOct 16th, 2019

The Week Ahead In Biotech: Pfenex And Clinuvel On The Radar Ahead of FDA Decisions, 2 IPOs On Deck

Notwithstanding the ESMO conference generating some huge moves in some stocks, last week turned out to be a muted one for biotechs. read more.....»»

Category: blogSource: benzingaOct 6th, 2019

Biotech Stock On The Radar: Anavex, A Neurology-Focused Precision Medicine Company

The European Rett Syndrome Conference gets underway Friday in Finland. Among the presenters: a New York-based micro-cap biotech that has an investigational asset to treat Rett syndrome in .....»»

Category: blogSource: benzingaSep 25th, 2019

Biotech Stock On The Radar: Medicines Company, A Cardiovascular Pure Play With A Potential Blockbuster

The Medicines Company (NASDAQ: MDCO) stock has staged a nice recovery in the first half of 2019 after a steep 60% pullback in the second half of 2018 that dragged it to a 52-week low of $1.....»»

Category: blogSource: benzingaAug 20th, 2019

The Week Ahead In Biotech: Vanda Awaits FDA Decision, BioVie Plans IPO

Biotech stocks came under pressure this week along with the broader market amid an earnings spate. read more.....»»

Category: blogSource: benzingaAug 11th, 2019

Ahead Of Earnings, Analysts Are Divided On Tesla

Tesla Motors Inc (NASDAQ: TSLA) is due to report its second quarter earnings July 24 after the closing bell. Though shares of the controversial automaker are down 16.5% year-to-date, the stock has rallied hard off.....»»

Category: blogSource: benzingaJul 24th, 2019

Edesa Biotech stock rockets 140% after FDA gives go-ahead to early-stage trial

Shares of Edesa Biotech Inc. shot up 140% in premarket trade after the Toronto-based company sa.....»»

Category: topSource: marketwatchJun 20th, 2019

The Week Ahead In Biotech: Conferences, PDUFA Dates Clinical Trial Readouts And IPOs

For bi.....»»

Category: blogSource: benzingaJun 15th, 2019

The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trial Readouts

Biot.....»»

Category: earningsSource: benzingaJun 8th, 2019

Iovance Issues Cancer Trial Updates Ahead Of ASCO Meeting, Sending Stock Skyward

Shares of small-cap biotech Iovance Biotherapeutics Inc (NASDAQ: IOVA) were making a strong upward move Thursday on more than 10 times their average volume.  read more.....»»

Category: blogSource: benzingaMay 16th, 2019